Displaying drugs 14301 - 14325 of 15036 in total
Ralinepag
Ralinepag has been used in trials studying the treatment of Pulmonary Arterial Hypertension.
Investigational
PF-05180999
PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
Investigational
DG051
DG051 is a novel small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H), the protein made by one of the genes in the leukotriene pathway that has been shown to link to risk of heart attack. DG051 is designed to decrease risk of heart attack by decreasing the production of leukotriene B4...
Investigational
Matched Description: … attack by decreasing the production of leukotriene B4 (LTB4), an end product of the leukotriene pathway and …
2,3-Dihydroxy-Benzoic Acid
Experimental
N-Benzyl-4-Sulfamoyl-Benzamide
Experimental
2-methyl-5-methylidenepyrimidin-4-imine
Experimental
Dihydrouracil
Experimental
Isopropyl beta-D-thiogalactopyranoside
A non-metabolizable galactose analog that induces expression of the LAC operon.
Experimental
1,4-dithio-alpha-D-glucopyranose
Experimental
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate
Experimental
Sucrosofate
Experimental
alpha-D-glucose 6-phosphate
Experimental
Ribose-5-phosphate
Experimental
N7-Methyl-Formycin A
Experimental
2-deoxy-2-fluoro-β-D-galactose
Experimental
Maltotetraose
Experimental
Alpha-D-Galactose-1-Phosphate
Experimental
N-beta-D-glucopyranosylacetamide
Experimental
Heparin Disaccharide Iii-S
Experimental
Displaying drugs 14301 - 14325 of 15036 in total